返回
OSE Immunotherapeutics SA（ORPOF）價格
ORPOF 股價走勢圖
ORPOF 收益
OSE Immunotherapeutics SA
$11.6
0%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$11.6
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$11.6
開盤價
$11.6
當日範圍
$11.6 - $11.6
52週區間
$11.6 - $11.6
交易量
748
平均成交量
0
每股盈餘 (TTM)
--
股息收益率
--
市值
$260.5M
什麼是 ORPOF？
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. The company is headquartered in Nantes, Pays De La Loire and currently employs 68 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.